Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy.
第一作者:
George,Papatheodoridis
第一单位:
2nd Department of Internal Medicine, Athens University Medical School, Hippokration Hospital of Athens, Greece; Academic Department of Gastroenterology, Athens University Medical School, Laikon Hospital of Athens, Greece. Electronic address: gepapath@med.uoa.gr.
作者:
关键词
ALTEntecavirHBVHBeAgHBsAgHepatitis BIQRInterferon-inducible protein 10LSMNA(s)PCRSDULNalanine aminotransferaseanti-HBeantibody against HBeAghepatitis B e antigenhepatitis B surface antigenhepatitis B virusinterquartile rangeliver stiffness measurementnucleos(t)ide analogue(s)polymerase chain reactionstandard deviationupper limit of normal
主题词
成年人(Adult);老年人(Aged);抗病毒药(Antiviral Agents);趋化因子CXCL10(Chemokine CXCL10);女(雌)性(Female);鸟嘌呤(Guanine);乙型肝炎表面抗原(Hepatitis B Surface Antigens);乙型肝炎e抗原(Hepatitis B e Antigens);乙型肝炎, 慢性(Hepatitis B, Chronic);人类(Humans);男(雄)性(Male);中年人(Middle Aged);比例危险度模型(Proportional Hazards Models)
DOI
10.1016/j.jhep.2013.08.023
PMID
24012614
发布时间
2014-11-20
- 浏览124
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文